BiotechTube
Home/NLS Pharmaceutics/Alex Zwyer
AZ

Alex Zwyer

Chief Executive Officer

NLS Pharmaceutics

Therapeutic Areas

Central Nervous System (CNS)Sleep-Wake Disorders

NLS Pharmaceutics Pipeline

DrugIndicationPhase
Mazindol ER (NLS-4 / Quilience®)Narcolepsy (Type 1 & 2)Phase 3
Mazindol ER (NLS-4)Attention-Deficit/Hyperactivity Disorder (ADHD)Phase 2

Leadership Team at NLS Pharmaceutics

EK
Eric Konofal
Chief Scientific Officer
CP
Chris Posner
Former Chairman of the Board
View full NLS Pharmaceutics profile